Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy

Xiaoding Xu, Jun Wu, Shuaishuai Liu, Phei Er Saw, Wei Tao, Yujing Li, Lisa Krygsman, S Yegnasubramanian, Angelo Michael Demarzo, Jinjun Shi, Charles J. Bieberich, Omid C. Farokhzad

Research output: Contribution to journalArticle

Abstract

Biodegradable polymeric nanoparticles (NPs) have demonstrated significant potential to improve the systemic delivery of RNA interference (RNAi) therapeutics, such as small interfering RNA (siRNA), for cancer therapy. However, the slow and inefficient siRNA release inside tumor cells generally observed for most biodegradable polymeric NPs may result in compromised gene silencing efficacy. Herein, a biodegradable and redox-responsive NP platform, composed of a solid poly(disulfide amide) (PDSA)/cationic lipid core and a lipid–poly(ethylene glycol) (lipid–PEG) shell for systemic siRNA delivery to tumor cells, is developed. This newly generated NP platform can efficiently encapsulate siRNA under extracellular environments and can respond to the highly concentrated glutathione (GSH) in the cytoplasm to induce fast intracellular siRNA release. By screening a library of PDSA polymers with different structures and chain lengths, the optimized NP platform shows the unique features of i) long blood circulation, ii) high tumor accumulation, iii) fast GSH-triggered intracellular siRNA release, and iv) exceptionally effective gene silencing. Together with the facile polymer synthesis technique and robust NP formulation enabling scale-up, this new redox-responsive NP platform may become an effective tool for RNAi-based cancer therapy.

Original languageEnglish (US)
JournalSmall
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

RNA Interference
RNA
Nanoparticles
Oxidation-Reduction
Small Interfering RNA
Neoplasms
Tumors
Gene Silencing
Amides
Disulfides
Therapeutics
Polymers
Genes
Cells
Ethylene Glycol
Blood Circulation
Hemodynamics
Chain length
Libraries
Glutathione

Keywords

  • biodegradable nanoparticle
  • cancer therapy
  • redox-responsive
  • siRNA delivery

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Engineering (miscellaneous)

Cite this

Xu, X., Wu, J., Liu, S., Saw, P. E., Tao, W., Li, Y., ... Farokhzad, O. C. (Accepted/In press). Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small. https://doi.org/10.1002/smll.201802565

Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. / Xu, Xiaoding; Wu, Jun; Liu, Shuaishuai; Saw, Phei Er; Tao, Wei; Li, Yujing; Krygsman, Lisa; Yegnasubramanian, S; Demarzo, Angelo Michael; Shi, Jinjun; Bieberich, Charles J.; Farokhzad, Omid C.

In: Small, 01.01.2018.

Research output: Contribution to journalArticle

Xu, X, Wu, J, Liu, S, Saw, PE, Tao, W, Li, Y, Krygsman, L, Yegnasubramanian, S, Demarzo, AM, Shi, J, Bieberich, CJ & Farokhzad, OC 2018, 'Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy', Small. https://doi.org/10.1002/smll.201802565
Xu, Xiaoding ; Wu, Jun ; Liu, Shuaishuai ; Saw, Phei Er ; Tao, Wei ; Li, Yujing ; Krygsman, Lisa ; Yegnasubramanian, S ; Demarzo, Angelo Michael ; Shi, Jinjun ; Bieberich, Charles J. ; Farokhzad, Omid C. / Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. In: Small. 2018.
@article{774d23cc639e4f3c8c59526787ab53ca,
title = "Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy",
abstract = "Biodegradable polymeric nanoparticles (NPs) have demonstrated significant potential to improve the systemic delivery of RNA interference (RNAi) therapeutics, such as small interfering RNA (siRNA), for cancer therapy. However, the slow and inefficient siRNA release inside tumor cells generally observed for most biodegradable polymeric NPs may result in compromised gene silencing efficacy. Herein, a biodegradable and redox-responsive NP platform, composed of a solid poly(disulfide amide) (PDSA)/cationic lipid core and a lipid–poly(ethylene glycol) (lipid–PEG) shell for systemic siRNA delivery to tumor cells, is developed. This newly generated NP platform can efficiently encapsulate siRNA under extracellular environments and can respond to the highly concentrated glutathione (GSH) in the cytoplasm to induce fast intracellular siRNA release. By screening a library of PDSA polymers with different structures and chain lengths, the optimized NP platform shows the unique features of i) long blood circulation, ii) high tumor accumulation, iii) fast GSH-triggered intracellular siRNA release, and iv) exceptionally effective gene silencing. Together with the facile polymer synthesis technique and robust NP formulation enabling scale-up, this new redox-responsive NP platform may become an effective tool for RNAi-based cancer therapy.",
keywords = "biodegradable nanoparticle, cancer therapy, redox-responsive, siRNA delivery",
author = "Xiaoding Xu and Jun Wu and Shuaishuai Liu and Saw, {Phei Er} and Wei Tao and Yujing Li and Lisa Krygsman and S Yegnasubramanian and Demarzo, {Angelo Michael} and Jinjun Shi and Bieberich, {Charles J.} and Farokhzad, {Omid C.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/smll.201802565",
language = "English (US)",
journal = "Small",
issn = "1613-6810",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy

AU - Xu, Xiaoding

AU - Wu, Jun

AU - Liu, Shuaishuai

AU - Saw, Phei Er

AU - Tao, Wei

AU - Li, Yujing

AU - Krygsman, Lisa

AU - Yegnasubramanian, S

AU - Demarzo, Angelo Michael

AU - Shi, Jinjun

AU - Bieberich, Charles J.

AU - Farokhzad, Omid C.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Biodegradable polymeric nanoparticles (NPs) have demonstrated significant potential to improve the systemic delivery of RNA interference (RNAi) therapeutics, such as small interfering RNA (siRNA), for cancer therapy. However, the slow and inefficient siRNA release inside tumor cells generally observed for most biodegradable polymeric NPs may result in compromised gene silencing efficacy. Herein, a biodegradable and redox-responsive NP platform, composed of a solid poly(disulfide amide) (PDSA)/cationic lipid core and a lipid–poly(ethylene glycol) (lipid–PEG) shell for systemic siRNA delivery to tumor cells, is developed. This newly generated NP platform can efficiently encapsulate siRNA under extracellular environments and can respond to the highly concentrated glutathione (GSH) in the cytoplasm to induce fast intracellular siRNA release. By screening a library of PDSA polymers with different structures and chain lengths, the optimized NP platform shows the unique features of i) long blood circulation, ii) high tumor accumulation, iii) fast GSH-triggered intracellular siRNA release, and iv) exceptionally effective gene silencing. Together with the facile polymer synthesis technique and robust NP formulation enabling scale-up, this new redox-responsive NP platform may become an effective tool for RNAi-based cancer therapy.

AB - Biodegradable polymeric nanoparticles (NPs) have demonstrated significant potential to improve the systemic delivery of RNA interference (RNAi) therapeutics, such as small interfering RNA (siRNA), for cancer therapy. However, the slow and inefficient siRNA release inside tumor cells generally observed for most biodegradable polymeric NPs may result in compromised gene silencing efficacy. Herein, a biodegradable and redox-responsive NP platform, composed of a solid poly(disulfide amide) (PDSA)/cationic lipid core and a lipid–poly(ethylene glycol) (lipid–PEG) shell for systemic siRNA delivery to tumor cells, is developed. This newly generated NP platform can efficiently encapsulate siRNA under extracellular environments and can respond to the highly concentrated glutathione (GSH) in the cytoplasm to induce fast intracellular siRNA release. By screening a library of PDSA polymers with different structures and chain lengths, the optimized NP platform shows the unique features of i) long blood circulation, ii) high tumor accumulation, iii) fast GSH-triggered intracellular siRNA release, and iv) exceptionally effective gene silencing. Together with the facile polymer synthesis technique and robust NP formulation enabling scale-up, this new redox-responsive NP platform may become an effective tool for RNAi-based cancer therapy.

KW - biodegradable nanoparticle

KW - cancer therapy

KW - redox-responsive

KW - siRNA delivery

UR - http://www.scopus.com/inward/record.url?scp=85053446368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053446368&partnerID=8YFLogxK

U2 - 10.1002/smll.201802565

DO - 10.1002/smll.201802565

M3 - Article

JO - Small

JF - Small

SN - 1613-6810

ER -